Manal Abdelmalek (@mayo_liverdoc) 's Twitter Profile
Manal Abdelmalek

@mayo_liverdoc

Liver specialist, educator, mentor, and clinical investigator. Passionate about discovery and innovation. Wife, mother, daughter, and sister.

ID: 3231850887

calendar_today03-05-2015 21:35:18

638 Tweet

1,1K Followers

489 Following

CLDFoundation (@cldfoundation) 's Twitter Profile Photo

"Use of Surrogate Markers and Algorithms to Identify High-Risk Patients and Optimize Outcomes" in our NASH/MASH session presented by Dr. Rohit Loomba Rohit Loomba is diving into how to enhance early detection, and tailor treatments more effectively! #LiverConnect #LiverTwitter

Manal Abdelmalek (@mayo_liverdoc) 's Twitter Profile Photo

Dr. Keyur Patel reviews DILI: 1) anti-infective most common cause globally.; 2) 50% have acute hepatocellular injury of which 10% may succumb to death or transplant-stop culprit drugs early! AASLD Jasmohan Bajaj

Dr. Keyur Patel reviews DILI: 1) anti-infective most common cause globally.;  2) 50% have  acute hepatocellular  injury of which 10% may succumb to death or transplant-stop culprit drugs early! <a href="/AASLDtweets/">AASLD</a> <a href="/JasmohanBajaj/">Jasmohan Bajaj</a>
Manal Abdelmalek (@mayo_liverdoc) 's Twitter Profile Photo

Forget drugs…maybe changes in gut microbiota is all we need to diagnose and treat cirrhosis, hepatic encephalopathy and predict mortality! Provocative.Jasmohan Bajaj Bilal Hameed AASLD

Forget drugs…maybe changes in gut microbiota is all we need to diagnose and treat cirrhosis, hepatic encephalopathy and predict mortality! Provocative.<a href="/JasmohanBajaj/">Jasmohan Bajaj</a> <a href="/BilalUCSF/">Bilal Hameed</a> <a href="/AASLDtweets/">AASLD</a>
FattyLiverAlliance (@fattylivera) 's Twitter Profile Photo

It is with a heavy heart that we at the Fatty Liver Alliance share the news of the sudden passing of Dr. Stephen A. Harrison, a distinguished hepatologist and cherished colleague to so many, on April 23, 2024. Dr. Harrison was a towering figure in the medical community, renowned

It is with a heavy heart that we at the Fatty Liver Alliance share the news of the sudden passing of Dr. Stephen A. Harrison, a distinguished hepatologist and cherished colleague to so many, on April 23, 2024. Dr. Harrison was a towering figure in the medical community, renowned
Henry E. Chang (@henryechang) 's Twitter Profile Photo

The patient advocacy community is shocked and deeply saddened by the sudden loss Dr. Stephen Harrison. A visionary in hepatology, Dr. Harrison foresaw many critical advancements and led the groundbreaking clinical studies that delivered the first U.S. FDA approved treatment for

The patient advocacy community is shocked and deeply saddened by the sudden loss Dr. Stephen Harrison. A visionary in hepatology, Dr. Harrison foresaw many critical advancements and led the groundbreaking clinical studies that delivered the first <a href="/US_FDA/">U.S. FDA</a> approved treatment for
Kara Wegermann (@kwegermann) 's Twitter Profile Photo

Sad to hear of Dr. Harrison’s passing. Had the honor of introducing him as emcee for Academic Debates at TLM 2023. He was an entertaining and gracious presence. Here he is laying down the law with esteemed judges ⁦Manal Abdelmalek⁩ ⁦Naga Chalasani⁩ ⁦Rotonya Carr

Sad to hear of Dr. Harrison’s passing. Had the honor of introducing him as emcee for Academic Debates at TLM 2023. He was an entertaining and gracious presence. Here he is laying down the law with esteemed judges ⁦<a href="/Mayo_liverdoc/">Manal Abdelmalek</a>⁩ ⁦<a href="/nagachalasani/">Naga Chalasani</a>⁩ ⁦<a href="/RotonyaC/">Rotonya Carr</a>⁩
AASLD (@aasldtweets) 's Twitter Profile Photo

With deep sadness, AASLD recognizes the passing of a great leader in the field. Dr. Stephen Harrison leaves behind an incredible legacy, particularly in NASH/MASH. Thank you Drs. Rinella, Tetri, and Brunt for your moving tribute, which you can read here: aasld.org/col-stephen-ha…

With deep sadness, AASLD recognizes the passing of a great leader in the field. Dr. Stephen Harrison leaves behind an incredible legacy, particularly in NASH/MASH. Thank you Drs. Rinella, Tetri, and Brunt for your moving tribute, which you can read here: aasld.org/col-stephen-ha…
EASLnews (@easlnews) 's Twitter Profile Photo

The liver community mourns the loss of Dr. Stephen Harrison, a friend and a visionary in MASLD clinics and clinical research, whose contributions have shaped the current state of the field. We extend our deepest condolences to Dr. Harrison’s family and colleagues during this

The liver community mourns the loss of Dr. Stephen Harrison, a friend and a visionary in MASLD clinics and clinical research, whose contributions have shaped the current state of the field. 

We extend our deepest condolences to Dr. Harrison’s family and colleagues during this
Manal Abdelmalek (@mayo_liverdoc) 's Twitter Profile Photo

Elliot Tapper GUILD Conference Indeed—Elliot Tapper and GUILD Conference. Maui 2022. A breathtaking experience with memories that last a lifetime. Glad neither one of fell out of that little boat as we gazed out at nature’s magnificence!

<a href="/ebtapper/">Elliot Tapper</a> <a href="/GuildConference/">GUILD Conference</a> Indeed—<a href="/ebtapper/">Elliot Tapper</a> and <a href="/GuildConference/">GUILD Conference</a>. Maui 2022.  A breathtaking experience with memories that last a lifetime.  Glad neither one of fell out of that little boat as we gazed out at nature’s magnificence!
Henry E. Chang (@henryechang) 's Twitter Profile Photo

Final results from the Phase 3 REGENERATE trial, presented today as a late-breaker poster (LBP-036) at #EASLCongress, demonstrated that #OCA 25 mg reduces histologic progression to cirrhosis in patients with pre-cirrhotic fibrosis due to #MASH. The study confirmed the

Final results from the Phase 3 REGENERATE trial, presented today as a late-breaker poster (LBP-036) at #EASLCongress, demonstrated that #OCA 25 mg reduces histologic progression to cirrhosis in patients with pre-cirrhotic fibrosis due to #MASH. The study confirmed the